Three national liver associations have renamed fatty liver disease as steatotic liver disease to be more “affirmative” and less stigmatising to patients, they announced at the European Association for the Study of the Liver’s (EASL) congress in Vienna.
Non-alcoholic fatty liver disease will now be called metabolic dysfunction associated steatotic liver disease (MASLD).
And a new category, MetALD, describes those with MASLD who consume greater amounts of alcohol a week (140 g a week for women and 210 g a week for men).
The renaming comes after a two year process led by the American Association for Study …